Relief Therapeutics (RLFTF) Stock Tries To Move Back to 30 cents: What Next?
In recent months, Relief Therapeutics Holdings AG (OTCMKTS:RLFTF) has been in considerable focus among investors due to its work in relation to RLF 100. The product, which is meant for treating patients suffering from severe symptoms of COVID 19 infection, is currently in advanced clinical development.
On Friday, the stock was on the move after the company announced that its Annual General Meeting is going to be hosted on June 18, 2021. The announcement was made on Thursday and on Friday, the Relief stock clocked gains of as much as 15% as investors piled on to it in a big way.
The company also pointed out that due to the circumstances owing to the coronavirus pandemic, shareholders would not need to be present in person at the meeting. Relief also pointed out that it sent out the instructions with regards to voting procedures to the shareholders as well.
In addition to that, the company also announced that set of agendas which are going to be deliberated at the meeting. However, there was another development on Friday that investors ought to keep in mind. The company announced on Friday that it appointed Taneli Jouhikainen as its new Chief Operating Officer.
The position was recently created by the company and Jouhikainen is going to take charge from June 1, 2021. The company had decided to create this position in order oversee the transition of Relief Therapeutics to a diversified product focussed company from a clinical stage firm.
Jouhikainen will be charged with overseeing all the product development initiatives and will also manage the intellectual property portfolio that is owned by Relief Therapeutics at this point. It is a significant appointment and one that could have a long term effect on the fortunes of Relief Therapeutics as a company. In light of these developments and the rally in the stock, it might be a good idea for investors to keep an eye on the Relief stock.
Can High Tide (HITID) stock Move Back To New Highs In June?
When a company gets the opportunity to list its shares in a large exchange then it is regarded as a major boost for the stock and that is what has happened with the High Tide Inc (OTCMKTS:HITID) stock on Friday. This past Friday the company announced that it got approval for listing its shares on the NASDAQ Capital Market.
The High Tide share is going to start trading on NASDAQ from June 2, 2021 under the ticker sign ‘HITI’. Considering the fact that NASDAQ is one of the biggest stock market exchanges in the world, the stock is going to get exposed to a much larger pool of capital and investors.
Hence, it goes without saying that it is a major development for High Tide and resulted in a considerable optimism among market participants. In this regard, it is also necessary to note that High Tide has been one of the better performers in the cannabis sector this year so far and has clocked gains of 190% in the period. While the stock is all set to be listed on NASDAQ, it is also important to note that the High Tide stock is going to continue to trade on the TSX Venture Exchange concurrently.
The Chief Executive Officer and President of the company Raj Grover spoke about the listing as well. He said that it is a major success for High Tide that it managed to be listed on NASDAQ in less than three years since its establishment as a company.
In addition to that, he went on to state that High Tide is also going to become the first major publicly trade cannabis retail company to trade NASDAQ. In addition to the exposure to a vast pool if investors, the listing is also going to make it easier for institutional investors to get involved with High Tide and that is another reason why it is a major development.